Literature DB >> 18401859

Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.

Fatih Ermis, Sadakat Ozdil, Filiz Akyüz, Binnur Pinarbasi, Zeynel Mungan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18401859     DOI： 10.1002/ibd.20481

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

1.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

2.  Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.

Authors:  Eva Zold; Arpad Nagy; Katalin Devenyi; Margit Zeher; Zsolt Barta
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

Review 3.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.